摘要:
springer.com
sci-hub.st 参考文章(131)
William Anderson, Asad Umar, Jaye Viner, Ernest Hawk, The role of cyclooxygenase inhibitors in cancer prevention. Current Pharmaceutical Design. ,vol. 8, pp. 1035- 1062 ,(2002) , 10.2174/1381612023394935
Bruce E Johnson, John V Heymach, None, Farnesyl Transferase Inhibitors for Patients with Lung Cancer Clinical Cancer Research. ,vol. 10, ,(2004) , 10.1158/1078-0432.CCR-040016
J.R Woodburn, The epidermal growth factor receptor and its inhibition in cancer therapy. Pharmacology & Therapeutics. ,vol. 82, pp. 241- 250 ,(1999) , 10.1016/S0163-7258(98)00045-X
Geoffrey I. Shapiro, J. Wade Harper, Anticancer drug targets: cell cycle and checkpoint control Journal of Clinical Investigation. ,vol. 104, pp. 1645- 1653 ,(1999) , 10.1172/JCI9054
John Goffin, Leonard Appleman, David Ryan, Panos Fidias, Joan Lucca, Eileen Regan, A Dimitrios Colevas, Joseph Paul Eder, Jeffrey Supko, Geoffrey Shapiro, None, P-348 A phase I trial of gemcitabine followed by flavopiridol in patients with solid tumors Lung Cancer. ,vol. 41, ,(2003) , 10.1016/S0169-5002(03)92316-6
S. Korfee, T. Gauler, R. Hepp, C. Pöttgen, W. Eberhardt, New targeted treatments in lung cancer--overview of clinical trials. Lung Cancer. ,vol. 45, ,(2004) , 10.1016/J.LUNGCAN.2004.07.974
Jyoti D. Patel, Vincent A. Miller, Mark G. Kris, Neelam T. Shah, Barbara Pizzo, Leslie Tyson, Maureen Zakowski, Natalie Memoli, Robert Heelan, David H. Johnson, O-188 Encouraging activity and durable responses demonstrated by the epithelial growth factor receptor-tyrosine kinase inhibitor, Erlotinib (Tarceva TM, OSI774), in patients with advanced bronchioloalveolar (BAC) cell carcinoma Lung Cancer. ,vol. 41, ,(2003) , 10.1016/S0169-5002(03)91846-0
Paul A. Bunn, The potential role of proteasome inhibitors in the treatment of lung cancer. Clinical Cancer Research. ,vol. 10, ,(2004) , 10.1158/1078-0432.CCR-040011
Grace K. Dy, Alex A. Adjei, Novel Targets for Lung Cancer Therapy: Part I Journal of Clinical Oncology. ,vol. 20, pp. 2881- 2894 ,(2002) , 10.1200/JCO.2002.11.145
Roman Perez-Soler, The role of erlotinib (Tarceva, OSI 774) in the treatment of non-small cell lung cancer. Clinical Cancer Research. ,vol. 10, ,(2004) , 10.1158/1078-0432.CCR-040017